Andrew Laccetti

4PUBLICATIONS
5CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
Abiraterone Acetate Affects Gene Expression Profile in a Human Male Neuronal Cell Line: Potential Mechanism for Cognitive Deficits with Prostate Cancer Therapy.

|Oct 09, 2023
A Phase 1, Open-label, Dose-Ascending Study to Evaluate the Safety and Tolerability of the Therapeutic Radiopharmaceutical 131I-MIP-1095 for the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Andrew L Laccetti, Lisa Bodei, Joseph A O'Donoghue

|Mar 02, 2021
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes.

Andrew L Laccetti, Benjamin Garmezy, Lianchun Xiao

|Jan 06, 2021
A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research.

Andrew L Laccetti, Michael J Morris, Philip W Kantoff

Pageof 1

Frequent Collaborators

1 joint publications

Michael J Morris

1 joint publications

Minas Economides

1 joint publications

Tian Zhang

1 joint publications

Allison B Reiss